Risk Factors for Endophthalmitis Requiring Evisceration or Enucleation
Authors
Affiliations
Endophthalmitis has devastating sequelae resulting in blindness and even loss of eyeball. Although the prognosis of endophthalmitis has much improved with the advances of antibiotics and vitreoretinal surgery, of the number of patients that required evisceration or enucleation is still significant. We retrospectively reviewed the charts of 210 eyes of 210 patients with endophthalmitis andcompared the group that required evisceration or enucleation with those that received salvaging therapies. Regression analysis was used to identify the risk factors for evisceration or enucleation. Thirty eyes (14.3%) underwent enucleation or evisceration. The group of eviscerated or enucleated eyes were older (58.7 vs. 42.2 years, p < 0.001), had more women (56.7% vs. 22.2%, p = 0.003), had poorer initial visual acuity (2.79 vs. 2.10 LogMAR, p < 0.001), and had longer duration before intervention (18.03 vs. 5.74 days, p = 0.031). The most common primary indications for endophthalmitis were infections from corneal ulcer (50.0% vs. 4.4%, p < 0.001) andfrom endogenous source (23.3% vs. 5.6%, p < 0.001). Less common indications were trauma (26.7% vs. 67.8%, p < 0.001) and postoperative (6.7% vs. 22.2%, p = 0.049) endophthalmitis. After adjusting for confounding factors, corneal ulcer-related endophthalmitis, endogenous endophthalmitis and initial visual acuity were the independent risk factors for evisceration or enucleation.
Clinical analysis of 101 cases of infectious endophthalmitis.
Li S, Song X, Wang X, Du X, Yang Z, Tao Y Medicine (Baltimore). 2025; 104(6):e40048.
PMID: 39928809 PMC: 11812999. DOI: 10.1097/MD.0000000000040048.
Application of metagenomic next-generation sequencing in the diagnosis of infectious diseases.
Zhao Y, Zhang W, Zhang X Front Cell Infect Microbiol. 2024; 14:1458316.
PMID: 39619659 PMC: 11604630. DOI: 10.3389/fcimb.2024.1458316.
Risk factors for endogenous endophthalmitis in infectious endocarditis patients.
Shah M, Zhu A, Uppuluri A, Henry R, Zarbin M, Bhagat N Eye (Lond). 2024; 39(1):125-132.
PMID: 39402169 PMC: 11733160. DOI: 10.1038/s41433-024-03390-w.
Wangdi L, Wai Wye N, Meng Hsien Y, Naffi A, Bastion M Cureus. 2024; 16(8):e65986.
PMID: 39221292 PMC: 11366068. DOI: 10.7759/cureus.65986.
Clinical characteristics and management outcome of acute infectious endophthalmitis.
Abrishami M, Abrishami M, Hatami N, Shoeibi N, Hosseini S, Ansari Astaneh M Int Ophthalmol. 2024; 44(1):308.
PMID: 38958789 DOI: 10.1007/s10792-024-03239-x.